Novanta (NOVT) Stock Price, News & Analysis

0 equities research analysts have issued twelve-month price targets for Novanta's stock. Their NOVT share price targets range from $161.00 to $161.00. On average, they anticipate the company's stock price to reach $161.00 in the next twelve months. This suggests a possible upside of 4.2% from the stock's current price.
View analysts price targets for NOVT or view top-rated stocks among Wall Street analysts.

Novanta's stock was trading at $168.41 at the beginning of the year. Since then, NOVT stock has decreased by 8.3% and is now trading at $154.50.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our NOVT earnings forecast.

Novanta will be holding an earnings conference call on Tuesday, May 7th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Novanta Inc. (NASDAQ:NOVT) issued its earnings results on Wednesday, February, 28th. The technology company reported $0.63 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.63. The technology company earned $211.60 million during the quarter, compared to the consensus estimate of $210.90 million. Novanta had a trailing twelve-month return on equity of 17.15% and a net margin of 8.27%. The firm's revenue for the quarter was down 3.1% on a year-over-year basis. During the same quarter last year, the business posted $0.75 earnings per share.

ETFs with the largest weight of Novanta (NASDAQ:NOVT) stock in their portfolio include Goldman Sachs Future Health Care Equity ETF (GDOC), ROBO Global Robotics & Automation ETF (ROBO), Franklin U.S. Small Cap Multifactor Index ETF (FLQS), VanEck Robotics ETF (IBOT), Nuveen ESG Small-Cap ETF (NUSC), Vanguard Russell 2000 Growth ETF (VTWG), iShares Russell 2000 Growth ETF (IWO) and Dimensional U.S. Small Cap ETF (DFAS).

Novanta updated its FY24 earnings guidance on Wednesday, February, 28th. The company provided EPS guidance of $3.10-$3.35 for the period, compared to the consensus EPS estimate of $3.22. The company issued revenue guidance of $975-$1.0 billion, compared to the consensus revenue estimate of $934.92 million.

44 employees have rated Novanta Chief Executive Officer Matthijs Glastra on Glassdoor.com. Matthijs Glastra has an approval rating of 87% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Novanta investors own include NVIDIA (NVDA), Alibaba Group (BABA), Gilead Sciences (GILD), Intuitive Surgical (ISRG), Lam Research (LRCX), Altria Group (MO), AT&T (T), Abiomed (ABMD), Advanced Micro Devices (AMD) and Broadcom (AVGO).

Novanta's stock is owned by many different institutional and retail investors. Top institutional shareholders include WoodTrust Financial Corp (0.01%) and Rise Advisors LLC (0.00%). Insiders that own company stock include Brian S Young, Matthijs Glastra, Robert Buckley and Thomas N Secor.
View institutional ownership trends.

Shares of NOVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.